AUSTIN (KXAN) — Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could “represent a paradigm shift” in virus treatment, according to the university.
UT researchers, working with international scientists, have developed a new type of antibody with a modified structure that can outsmart human cytomegalovirus (HCMV) and neutralize its ability to evade the immune system, according to a press release from Texas Biologics.
Texas Biologics described HCMV as a “common but overlooked virus that poses serious risks to vulnerable populations, including people with compromised immune systems.” According to the Centers for Disease Control and Prevention, the virus is the most infectious cause of birth defects in the United States…